- Home
- NYMT vs ARCT Comparison
NYMT vs ARCT Comparison
Compare NYMT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- ARCT
- Stock Information
- Founded
- NYMT 2003
- ARCT 2013
- Country
- NYMT United States
- ARCT United States
- Employees
- NYMT N/A
- ARCT N/A
- Industry
- NYMT Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- NYMT Real Estate
- ARCT Health Care
- Exchange
- NYMT Nasdaq
- ARCT Nasdaq
- Market Cap
- NYMT 538.5M
- ARCT 444.5M
- IPO Year
- NYMT 2004
- ARCT N/A
- Fundamental
- Price
- NYMT $5.43
- ARCT $10.53
- Analyst Decision
- NYMT Buy
- ARCT Strong Buy
- Analyst Count
- NYMT 5
- ARCT 7
- Target Price
- NYMT $7.13
- ARCT $57.80
- AVG Volume (30 Days)
- NYMT 879.3K
- ARCT 462.9K
- Earning Date
- NYMT 04-30-2025
- ARCT 05-07-2025
- Dividend Yield
- NYMT 14.72%
- ARCT N/A
- EPS Growth
- NYMT N/A
- ARCT N/A
- EPS
- NYMT N/A
- ARCT N/A
- Revenue
- NYMT $143,242,000.00
- ARCT $152,310,000.00
- Revenue This Year
- NYMT N/A
- ARCT N/A
- Revenue Next Year
- NYMT $20.60
- ARCT $39.21
- P/E Ratio
- NYMT N/A
- ARCT N/A
- Revenue Growth
- NYMT N/A
- ARCT N/A
- 52 Week Low
- NYMT $5.01
- ARCT $8.04
- 52 Week High
- NYMT $7.25
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- NYMT 32.50
- ARCT 43.14
- Support Level
- NYMT $5.30
- ARCT $10.07
- Resistance Level
- NYMT $5.61
- ARCT $11.00
- Average True Range (ATR)
- NYMT 0.33
- ARCT 0.88
- MACD
- NYMT -0.07
- ARCT 0.26
- Stochastic Oscillator
- NYMT 26.92
- ARCT 77.81
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.